|
2018
|
Invention
|
Conjugate based systems for controlled insulin delivery. The present disclosure provides conjugat... |
|
2017
|
Invention
|
Conjugate based systems for controlled drug delivery. Conjugates which comprise a drug and a liga... |
|
2016
|
Invention
|
Crystalline insulin-conjugates.
The present disclosure provides crystalline insulin-conjugates. ... |
|
|
Invention
|
Conjugate based systems for controlled drug delivery.
Conjugates which comprise a drug and a lig... |
|
2014
|
Invention
|
Binding-site modified lectins and uses thereof. In one aspect, the disclosure provides cross-link... |
|
|
Invention
|
Crystalline insulin-conjugates. The present disclosure provides crystalline insulin-conjugates. T... |
|
|
Invention
|
Exogenously triggered controlled release materials and uses thereof. The disclosure provides cros... |
|
2013
|
Invention
|
Terminally-functionalized conjugates and uses thereof. The present disclosure provides inter alia... |
|
|
Invention
|
Soluble non-depot insulin conjugates and uses thereof.
In one aspect, the disclosure provides a ... |
|
2012
|
Invention
|
Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the ... |
|
2011
|
Invention
|
Uses of macrophage mannose receptor to screen compounds and uses of these compounds. Methods and ... |
|
|
Invention
|
Recombinant lectins, binding-site modified lectins and uses thereof. In one aspect, the disclosur... |
|
|
Invention
|
Drug-ligand conjugates, synthesis thereof, and intermediates thereto. 2, and W are as defined and... |
|
|
Invention
|
Recombinantly expressed insulin polypeptides and uses thereof. The present disclosure provides re... |
|
|
Invention
|
Drug-ligand conjugates, synthesis thereof, and intermediates thereto.
The present invention rela... |
|
|
Invention
|
Drug-ligand conjugates, synthesis thereof, and intermediates thereto. The present invention relat... |
|
2010
|
Invention
|
Soluble non-depot insulin conjugates and uses thereof. In one aspect, the disclosure provides a c... |
|
|
Invention
|
Polynucleotide aptamer-based cross-linked materials and uses thereof. In one aspect, the disclosu... |
|
|
Invention
|
Binding-site modified lectins and uses thereof.
In one aspect, the disclosure provides cross-lin... |
|
|
Invention
|
Polynucleotide aptamer-based cross -linked materials and uses thereof. In one aspect, the disclos... |
|
|
Invention
|
Synthetic conjugates and uses thereof. The present disclosure provides a cross-linked material co... |
|
|
Invention
|
Methods for reducing the mitogenicity of lectin compositions. Methods for reducing the T-cell mit... |
|
2006
|
Invention
|
Polymer-drug conjugates.
A conjugate that includes a drug covalently linked to a polymer. Upon a... |
|
|
Invention
|
Polymer-drug conjugates. A conjugate that includes a drag covalently linked to a polymer. Upon ad... |
